Home > Healthcare > Biotechnology > Biopharma > Carcinoembryonic Antigen Market

Carcinoembryonic Antigen Market Share

  • Report ID: GMI427
  • Published Date: Jan 2019
  • Report Format: PDF
 Download Free Sample

Carcinoembryonic Antigen Market Share

Global carcinoembryonic antigen market share is competitive in nature and dominated by limited number of players. Companies operating in the market includes

  • F. Hoffmann-La Roche Ltd.
  • Quest Diagnostics
  • GenWay Biotech Inc.
  • Correlogic Systems, Inc.
  • Creative Diagnostics
  • Omega Diagnostics Group PLC
  • RayBiotech, Inc.
  • Boster Biological Technology

Companies operating in this industry are focusing on strategies such as mergers and acquisitions to maintain leadership position. Manufacturer face constant pressure to introduce new and technologically advanced products with more sensitivity in the market.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of carcinoembryonic antigen surpassed USD 1.9 billion in 2017.

The industry share of carcinoembryonic antigen is expected to witness more than 6.7% CAGR from 2018 to 2024.

Carcinoembryonic Antigen (CEA) Market Scope

  • Carcinoembryonic Antigen (CEA) Market Size
  • Carcinoembryonic Antigen (CEA) Market Analysis
  • Carcinoembryonic Antigen (CEA) Market Share

    • Buy Now

    Immediate Delivery Available

    Premium Report Details

    • Base Year: 2017
    • Companies covered: 8
    • Tables & Figures: 412
    • Countries covered: 30
    • Pages: 280
     Download Free Sample
    ×
    Get a free sample of Carcinoembryonic Antigen (CEA) Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.